Notably, Padi4-high groups showed a decreased DMFS specifically for lung but not for brain, bone or liver metastasis in patients with triple negative breast cancer (TNBC) (Extended Data Fig. 10d). This evidence concerns the gene PADI4 and triple-negative breast carcinoma.